An Integrative Pan-Cancer Analysis of PBK in Human Tumors

Background: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Huantao Wen, Zitao Chen, Min Li, Qiongzhen Huang, Yuhao Deng, Jiawei Zheng, Moliang Xiong, Pengfei Wang, Wangming Zhang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
PBK
Acceso en línea:https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:07eb1fecbc8f4a0f928234d9b270337a
record_format dspace
spelling oai:doaj.org-article:07eb1fecbc8f4a0f928234d9b270337a2021-11-10T07:31:41ZAn Integrative Pan-Cancer Analysis of PBK in Human Tumors2296-889X10.3389/fmolb.2021.755911https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fmolb.2021.755911/fullhttps://doaj.org/toc/2296-889XBackground: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this study, we systematically explored the prognostic and predictive value of PBK expression in 33 cancer types.Methods: Public databases including the cBioPortal database, GDSC database, GTEx database, CCLE database, and TCGA database were used to detect the PBK expression and its association with the prognosis, clinicopathologic stage, TMB, MSI, immune microenvironment, immune checkpoints, immune cell infiltration, enrichment pathways, and IC50 across pan-cancer. The statistical analyses and visualization were conducted using R software.Results: PBK expression is relatively high in most cancers compared to their normal counterparts, and this gene is barely expressed in normal tissues. High expression of PBK is significantly associated with poor prognosis and clinicopathologic stages I, II, and III in different cancers. Furthermore, PBK expression is strongly associated with TMB in 23 cancer types and associated with MSI in nine cancer types. Moreover, the correlation analysis of the microenvironment and immune cells indicated that PBK is negatively correlated with the immune infiltration levels but positively correlated with the infiltration levels of M0 and M1 macrophages, T cells CD4 memory activated, and T cells follicular helper. GSEA analysis revealed that the biological function or pathways relevant to the cell cycle and mitosis were frequently enriched at the level of high expression of PBK.Conclusion: These results revealed the oncogenic role of PBK, which is significantly upregulated in various cancers and indicated poor prognosis and immune infiltration in multiple cancers. It also suggested that PBK may serve as a biomarker in multiple tumor progress and patient survival.Huantao WenZitao ChenMin LiQiongzhen HuangYuhao DengJiawei ZhengMoliang XiongPengfei WangWangming ZhangFrontiers Media S.A.articlepan-cancerPBKbiomarkertumor cell proliferationprognosisBiology (General)QH301-705.5ENFrontiers in Molecular Biosciences, Vol 8 (2021)
institution DOAJ
collection DOAJ
language EN
topic pan-cancer
PBK
biomarker
tumor cell proliferation
prognosis
Biology (General)
QH301-705.5
spellingShingle pan-cancer
PBK
biomarker
tumor cell proliferation
prognosis
Biology (General)
QH301-705.5
Huantao Wen
Zitao Chen
Min Li
Qiongzhen Huang
Yuhao Deng
Jiawei Zheng
Moliang Xiong
Pengfei Wang
Wangming Zhang
An Integrative Pan-Cancer Analysis of PBK in Human Tumors
description Background: PDZ binding kinase (PBK) is a serine/threonine kinase, which belongs to the mitogen-activated protein kinase kinase (MAPKK) family. It has been shown to be a critical gene in the regulation of mitosis and tumorigenesis, but the role of PBK in various cancers remains unclear. In this study, we systematically explored the prognostic and predictive value of PBK expression in 33 cancer types.Methods: Public databases including the cBioPortal database, GDSC database, GTEx database, CCLE database, and TCGA database were used to detect the PBK expression and its association with the prognosis, clinicopathologic stage, TMB, MSI, immune microenvironment, immune checkpoints, immune cell infiltration, enrichment pathways, and IC50 across pan-cancer. The statistical analyses and visualization were conducted using R software.Results: PBK expression is relatively high in most cancers compared to their normal counterparts, and this gene is barely expressed in normal tissues. High expression of PBK is significantly associated with poor prognosis and clinicopathologic stages I, II, and III in different cancers. Furthermore, PBK expression is strongly associated with TMB in 23 cancer types and associated with MSI in nine cancer types. Moreover, the correlation analysis of the microenvironment and immune cells indicated that PBK is negatively correlated with the immune infiltration levels but positively correlated with the infiltration levels of M0 and M1 macrophages, T cells CD4 memory activated, and T cells follicular helper. GSEA analysis revealed that the biological function or pathways relevant to the cell cycle and mitosis were frequently enriched at the level of high expression of PBK.Conclusion: These results revealed the oncogenic role of PBK, which is significantly upregulated in various cancers and indicated poor prognosis and immune infiltration in multiple cancers. It also suggested that PBK may serve as a biomarker in multiple tumor progress and patient survival.
format article
author Huantao Wen
Zitao Chen
Min Li
Qiongzhen Huang
Yuhao Deng
Jiawei Zheng
Moliang Xiong
Pengfei Wang
Wangming Zhang
author_facet Huantao Wen
Zitao Chen
Min Li
Qiongzhen Huang
Yuhao Deng
Jiawei Zheng
Moliang Xiong
Pengfei Wang
Wangming Zhang
author_sort Huantao Wen
title An Integrative Pan-Cancer Analysis of PBK in Human Tumors
title_short An Integrative Pan-Cancer Analysis of PBK in Human Tumors
title_full An Integrative Pan-Cancer Analysis of PBK in Human Tumors
title_fullStr An Integrative Pan-Cancer Analysis of PBK in Human Tumors
title_full_unstemmed An Integrative Pan-Cancer Analysis of PBK in Human Tumors
title_sort integrative pan-cancer analysis of pbk in human tumors
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/07eb1fecbc8f4a0f928234d9b270337a
work_keys_str_mv AT huantaowen anintegrativepancanceranalysisofpbkinhumantumors
AT zitaochen anintegrativepancanceranalysisofpbkinhumantumors
AT minli anintegrativepancanceranalysisofpbkinhumantumors
AT qiongzhenhuang anintegrativepancanceranalysisofpbkinhumantumors
AT yuhaodeng anintegrativepancanceranalysisofpbkinhumantumors
AT jiaweizheng anintegrativepancanceranalysisofpbkinhumantumors
AT moliangxiong anintegrativepancanceranalysisofpbkinhumantumors
AT pengfeiwang anintegrativepancanceranalysisofpbkinhumantumors
AT wangmingzhang anintegrativepancanceranalysisofpbkinhumantumors
AT huantaowen integrativepancanceranalysisofpbkinhumantumors
AT zitaochen integrativepancanceranalysisofpbkinhumantumors
AT minli integrativepancanceranalysisofpbkinhumantumors
AT qiongzhenhuang integrativepancanceranalysisofpbkinhumantumors
AT yuhaodeng integrativepancanceranalysisofpbkinhumantumors
AT jiaweizheng integrativepancanceranalysisofpbkinhumantumors
AT moliangxiong integrativepancanceranalysisofpbkinhumantumors
AT pengfeiwang integrativepancanceranalysisofpbkinhumantumors
AT wangmingzhang integrativepancanceranalysisofpbkinhumantumors
_version_ 1718440437990031360